Boxer Capital, LLC
Follow13F filer, CIK 1465837, San Diego, CA
Boxer Capital, LLC reported $0 across 1 holding for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001213900-25-014355
- Period
- 2024-12-31
- Reported value
- $0
- Holdings
- 1
- Top 10 weight
- New
- 1
- Sold out
- 68
Largest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| RVMDexited | -4,279,464 | -$194M |
| TYRAexited | -6,448,359 | -$152M |
| NUVLexited | -1,120,192 | -$115M |
| ONCexited | -500,000 | -$112M |
| CYTKexited | -2,100,000 | -$111M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q4 2024
Share positions as resolved from 13F-HR 0001213900-25-014355, largest first. % of portfolio is the value over $0, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| 00 | 0 | $0 | new | Value filed as zero, left out of ratios.Amount filed as zero, left out of ratios. |
Sold out in Q4 2024
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| RVMDREVOLUTION MEDICINES INC | 4,279,464 | $194M | shares |
| TYRATYRA BIOSCIENCES INC | 6,448,359 | $152M | shares |
| NUVLNUVALENT INC | 1,120,192 | $115M | shares |
| ONCBEONE MEDICINES LTD | 500,000 | $112M | shares |
| CYTKCYTOKINETICS INC | 2,100,000 | $111M | shares |
| SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INC | 3,421,541 | $110M | shares |
| MERUS N VMERUS N V | 1,900,000 | $94.9M | shares |
| SRPTSAREPTA THERAPEUTICS INC | 650,000 | $81.2M | shares |
| RNAMAVIDITY BIOSCIENCES INC | 1,727,388 | $79.3M | shares |
| IDYAIDEAYA BIOSCIENCES INC | 2,202,812 | $69.8M | shares |
| TNGXTANGO THERAPEUTICS INC | 8,198,642 | $63.1M | shares |
| ARGXARGENX SE | 100,000 | $54.2M | shares |
| APLSAPELLIS PHARMACEUTICALS INC | 1,726,000 | $49.8M | shares |
| AKROAKERO THERAPEUTICS INC | 1,676,733 | $48.1M | shares |
| ANABANAPTYSBIO INC | 1,300,000 | $43.5M | shares |
| AXSMAXSOME THERAPEUTICS INC. | 400,000 | $35.9M | shares |
| ITEOS THERAPEUTICS INCITEOS THERAPEUTICS INC | 2,946,915 | $30.1M | shares |
| LEGNLEGEND BIOTECH CORP | 600,000 | $29.2M | shares |
| GERNGERON CORP | 6,000,000 | $27.2M | shares |
| THRDTHIRD HARMONIC BIO INC | 2,000,000 | $27.1M | shares |
| RCKTROCKET PHARMACEUTICALS INC | 1,466,051 | $27.1M | shares |
| RCUSARCUS BIOSCIENCES INC | 1,602,200 | $24.5M | shares |
| TILINSTIL BIO INC | 355,500 | $23.9M | shares |
| XENEXENON PHARMACEUTICALS INC | 600,000 | $23.6M | shares |
| IMVTIMMUNOVANT INC | 825,000 | $23.5M | shares |
| KYMRKYMERA THERAPEUTICS INC | 450,000 | $21.3M | shares |
| SYRESPYRE THERAPEUTICS INC | 696,480 | $20.5M | shares |
| KURAKURA ONCOLOGY INC | 1,000,000 | $19.5M | shares |
| KALVKALVISTA PHARMACEUTICALS INC | 1,590,000 | $18.4M | shares |
| NKTXNKARTA INC | 4,029,606 | $18.2M | shares |
| ORICORIC PHARMACEUTICALS INC | 1,732,571 | $17.8M | shares |
| GPCRSTRUCTURE THERAPEUTICS INC | 400,000 | $17.6M | shares |
| FATEFATE THERAPEUTICS INC | 4,960,910 | $17.4M | shares |
| ELVNENLIVEN THERAPEUTICS INC | 671,358 | $17.1M | shares |
| REPLREPLIMUNE GROUP INC | 1,536,341 | $16.8M | shares |
| DAWNDAY ONE BIOPHARMACEUTICALS I | 1,189,943 | $16.6M | shares |
| CGEMCULLINAN THERAPEUTICS INC | 907,895 | $15.2M | shares |
| ARVNARVINAS INC | 608,614 | $15M | shares |
| CLYMCLIMB BIO INC | 2,603,190 | $13.3M | shares |
| RLAYRELAY THERAPEUTICS INC | 1,819,132 | $12.9M | shares |
| NRIXNURIX THERAPEUTICS INC | 563,067 | $12.7M | shares |
| PRTAPROTHENA CORP PLC | 690,000 | $11.5M | shares |
| QUREUNIQURE NV | 2,225,000 | $11M | shares |
| APGEAPOGEE THERAPEUTICS INC | 179,000 | $10.5M | shares |
| OLMAOLEMA PHARMACEUTICALS INC | 650,000 | $7.76M | shares |
| IOVAIOVANCE BIOTHERAPEUTICS INC | 750,000 | $7.04M | shares |
| IPSCCENTURY THERAPEUTICS INC | 3,900,000 | $6.67M | shares |
| JSPRJASPER THERAPEUTICS INC | 350,000 | $6.58M | shares |
| SANASANA BIOTECHNOLOGY INC | 1,545,000 | $6.43M | shares |
| TERNTERNS PHARMACEUTICALS INC | 752,000 | $6.27M | shares |
| SRRKSCHOLAR ROCK HLDG CORP | 750,000 | $6.01M | shares |
| POSEIDA THERAPEUTICS INCPOSEIDA THERAPEUTICS INC | 2,000,000 | $5.72M | shares |
| SMMTSUMMIT THERAPEUTICS INC | 250,000 | $5.47M | shares |
| ENGNENGENE HOLDINGS INC | 727,900 | $4.8M | shares |
| PRLDPRELUDE THERAPEUTICS INC | 1,708,187 | $3.54M | shares |
| BCAXBICARA THERAPEUTICS INC | 135,000 | $3.44M | shares |
| Mersana Therapeutics IncMersana Therapeutics Inc | 1,817,000 | $3.43M | shares |
| BOLDBOUNDLESS BIO INC | 711,329 | $2.47M | shares |
| BDTXBLACK DIAMOND THERAPEUTICS I | 506,000 | $2.2M | shares |
| ZNTLZENTALIS PHARMACEUTICALS INC | 450,000 | $1.66M | shares |
| TARAPROTARA THERAPEUTICS INC | 811,627 | $1.49M | shares |
| OBIOORCHESTRA BIOMED HLDGS INC | 238,193 | $1.22M | shares |
| ZURAZURA BIO LTD | 300,000 | $1.22M | shares |
| BCABBIOATLA INC | 686,347 | $1.21M | shares |
| MISTMILESTONE PHARMACEUTICALS IN | 309,007 | $470K | shares |
| DBV TECHNOLOGIES S ADBV TECHNOLOGIES S A | 250,000 | $175K | shares |
| NUVATION BIO INCNUVATION BIO INC | 266,666 | $26.1K | shares |
| SRZNWSURROZEN INC | 66,666 | $1.33K | shares |
How Q4 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001213900-25-014355 | base | 2025-02-14 | acceptance time not in the bulk data set |
Filings
Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001213900-25-014355 | Quarter ended 2024-12-31 | 2025-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000895345-24-000585 | Quarter ended 2024-09-30 | 2024-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000895345-24-000355 | Quarter ended 2024-06-30 | 2024-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000895345-24-000182 | Quarter ended 2024-03-31 | 2024-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0000895345-24-000061 | Quarter ended 2023-12-31 | 2024-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000895345-23-000631 | Quarter ended 2023-09-30 | 2023-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000895345-23-000469 | Quarter ended 2023-06-30 | 2023-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000895345-23-000296 | Quarter ended 2023-03-31 | 2023-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0000895345-23-000135 | Quarter ended 2022-12-31 | 2023-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-22-012323 | Quarter ended 2022-09-30 | 2022-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-22-009489 | Quarter ended 2022-06-30 | 2022-08-15 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-22-006483 | Quarter ended 2022-03-31 | 2022-05-16 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-22-003002 | Quarter ended 2021-12-31 | 2022-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-21-015597 | Quarter ended 2021-09-30 | 2021-11-15 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-21-011427 | Quarter ended 2021-06-30 | 2021-08-16 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-21-007061 | Quarter ended 2021-03-31 | 2021-05-17 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-21-002862 | Quarter ended 2020-12-31 | 2021-02-16 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000950123-20-012232 | Quarter ended 2020-09-30 | 2020-11-17 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-20-012197 | Quarter ended 2020-09-30 | 2020-11-16 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-20-009123 | Quarter ended 2020-06-30 | 2020-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-20-005395 | Quarter ended 2020-03-31 | 2020-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-20-002532 | Quarter ended 2019-12-31 | 2020-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-19-011467 | Quarter ended 2019-09-30 | 2019-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000950123-19-008514 | Quarter ended 2019-06-30 | 2019-08-15 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-19-008398 | Quarter ended 2019-06-30 | 2019-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-19-005411 | Quarter ended 2019-03-31 | 2019-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-19-002250 | Quarter ended 2018-12-31 | 2019-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-18-011923 | Quarter ended 2018-09-30 | 2018-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-18-008984 | Quarter ended 2018-06-30 | 2018-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-18-005733 | Quarter ended 2018-03-31 | 2018-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-18-002428 | Quarter ended 2017-12-31 | 2018-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-17-010901 | Quarter ended 2017-09-30 | 2017-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-17-008000 | Quarter ended 2017-06-30 | 2017-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-17-005338 | Quarter ended 2017-03-31 | 2017-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-17-002487 | Quarter ended 2016-12-31 | 2017-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-16-022431 | Quarter ended 2016-09-30 | 2016-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-16-020185 | Quarter ended 2016-06-30 | 2016-08-15 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-16-017634 | Quarter ended 2016-03-31 | 2016-05-16 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-16-015087 | Quarter ended 2015-12-31 | 2016-02-16 | acceptance time not in the bulk data set |